Skip to main content
DCTH
NASDAQ Life Sciences

Delcath Q2 Revenue Beats by 11%, Raises 2026 Guidance to $104M-$108M

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$14.5
Mkt Cap
$436.008M
52W Low
$8.12
52W High
$13.74
52W Position info
79% above low
Off High info
at 52W high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

DCTH sits 79% above its 52-week low of $8.12.

Summary

Delcath Systems reported Q2 revenue of $29.13M, beating the $26.26M consensus by 11%, with net income flat year-over-year at $2.67M. The company raised its full-year 2026 revenue guidance to $104M-$108M, up from prior expectations, and now anticipates positive adjusted EBITDA for the year. HEPZATO volume grew approximately 30% year-over-year, driven by treatment center expansion and physician adoption. This follows a Q1 that showed strong revenue growth but a net loss; the Q2 profit and raised outlook signal accelerating commercial traction. With the stock trading near its 52-week high, the guidance raise and margin targets (86%-89% gross margin) provide concrete upside catalysts.

Updates

  1. · SEC 10-Q — The 10-Q shows Q2 product revenue of $29.13M, net income of $2.67M, and HEPZATO KIT revenue of $27.16M. It also discloses $16.0M remaining under the share repurchase program.

At the time of this announcement, DCTH was trading at $14.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $436M. The 52-week trading range was $8.12 to $13.74. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

DCTH - Latest Insights

DCTH
Nov 09, 2026, 11:17 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $18.77
Real-time Price: $19.18 info
Change: +$0.410 (+2%) info
Market Cap: $666.539M info
DCTH
Nov 09, 2026, 9:01 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $18.00
Real-time Price: $19.18 info
Change: +$1.18 (+7%) info
Market Cap: $666.539M info
DCTH
Nov 09, 2026, 8:02 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $16.68
Real-time Price: $19.18 info
Change: +$2.50 (+15%) info
Market Cap: $666.539M info
DCTH
Nov 09, 2026, 8:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $14.94
Real-time Price: $19.18 info
Change: +$4.24 (+28%) info
Market Cap: $666.539M info
DCTH
Aug 06, 2026, 9:09 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $14.00
Real-time Price: $19.18 info
Change: +$5.18 (+37%) info
Market Cap: $666.539M info